Wednesday, November 30, 2016

Hope for Alcohol Abuse



Alcoholism is a pretty serious topic. I’m sure we all know at least one person who suffers from alcoholism or alcohol dependence. For me, it’s my grandfather. He’s been a heavy drinker since I was a little kid. I don’t think I’ve ever seen the man sober. According to the National Council on Alcoholism and Drug Dependence, 17.6 people suffer from alcohol abuse or dependence. But what of there was a way to decrease the desire to drink?

Researcher have identified a gene that suppresses the desire to drink. In a study, researchers looked at 105,00 light and heavy drinkers and found that a variation of the β-Klotho gene was linked to how much alcohol was consumed by participants. The less common variant of the gene was associated with the desire to consume. Those who had this variant tended to consume less alcohol than those who didn’t have it. This gene is associated with alcohol consumption because it directs the production of the β-Klotho protein that forms part of a receptor in the brain.

It is possible that this research could lead to medications for alcoholism and alcohol dependence. While drugs to combat these issues would be great, I know my grandfather would never consider taking a medication. You can’t force someone to take a drug. People still have to want to get better. Do you think these medications would be effective in decreasing alcohol related issues?    

Further Readings:
http://www.pnas.org/content/early/2016/11/22/1611243113
http://www.utsouthwestern.edu/newsroom/news-releases/year-2016/nov/social-drinking.html


Saturday, November 26, 2016

Astrovirus Vaccine



An astrovirus is a type of virus that just about everyone gets when they’re a kid. It usually isn’t anything too serious. Just the typical flu symptoms, vomiting, fever, etc.  However, these viruses can be dangerous for children undergoing chemotherapy because their immune systems are already degraded.  They can also infect the elderly and others with weakened immune systems. 

Researchers at The University of California Santa Cruz are working on antiviral therapies and vaccines for these viruses. They used x-ray crystallography to see how a specific protein structure on the surface of the virus is blocked by an antibody. They were able to see how the antibody binds to the astrovirus capsid spike domain. The antibody can stop the virus from attaching to a human cell. This site of the virus can be targeted for developing antiviral therapies and vaccines. 

A vaccine or antiviral medicines for these viruses would be a huge success. Not only could it help those already mentioned, it could also help those suffering from autoimmune diseases and HIV. While I won’t be jumping in line to get the vaccine, as I don’t think I really need it, I would definitely want my aging grandmother to.

Further Readings:
http://jvi.asm.org/content/early/2016/10/27/JVI.01859-16

Wednesday, November 23, 2016

Zika Replicons



I’m sure that by now most of us are pretty familiar with the Zika virus. Just in case you aren’t, I’ll give a little background. A person becomes infected with the virus when an infected mosquito bites them. In most cases, Zika isn’t that serious. Some may experience mild symptoms while others don’t experience any at all. However, if a woman is pregnant when she becomes infected, the virus can also infect the fetus causing serious birth defects. As of right now, there is no vaccine for the virus. 

BUT researchers are on their way to finding one. Researcher from Texas, China, and Belgium are working together on a tool called a “replicon system”. Replicons are bits of the viral genome that are able to replicate without the machinery of a host cell. Replicons are used in drug development for studying viruses. For this research, an experimental system was made that creates replicons of the Zika virus that don’t have the genes that make the virus infectious.  Making this form of the virus less dangerous to work with and study. The replicons can be used to locate parts of the virus that block replication. Researcher are able to attach genes to the replicons so they can tag parts of the virus they want to study. This information can be used in vaccine development because it can show how the virus is mutating and evolving.

While we still don’t have a vaccine for this virus right now, we might be looking at one sooner than we would have thought.

Further Readings:
http://www.ebiomedicine.com/article/S2352-3964(16)30420-0/pdf